ESC 365 - Effectiveness and safety of continued oral anticoagulation treatment beyond 1 year after venous thromboembolism in patients at intermediate risk: a nationwide propensity score weighted-cohort study

ESC Premium Access

Effectiveness and safety of continued oral anticoagulation treatment beyond 1 year after venous thromboembolism in patients at intermediate risk: a nationwide propensity score weighted-cohort study

Session: After pulmonary embolism: optimising treatment and follow up

Topic: Acute pulmonary embolism

Speaker: Professor S. Johnsen (Aalborg, DK)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Soeren Paaske Johnsen

Department of Clinical Medicine, Aalborg (Denmark)

1 presentation

0 follower

4 more presentations in this session

State of the Art: acute treatment of pulmonary embolism

Speaker: Professor N. Kucher (Zurich, CH)

Determinants of the long-term haemodynamic course and late sequelae after acute intermediate-risk pulmonary embolism: results from a randomized thrombolysis trial

Speaker: Doctor S. Barco (Zurich, CH)

Validation of the VTE-BLEED score for predicting 30-day major bleeding in a real-world cohort of patients with pulmonary embolism

Speaker: Mr K. Kresoja (Leipzig, DE)

Selecting the optimal duration and regimen of anticoagulation after pulmonary embolism

Speaker: Professor S. Konstantinides (Mainz, DE)

Access the full session

After pulmonary embolism: optimising treatment and follow up

Speakers: Professor S. Johnsen, Professor N. Kucher, Doctor S. Barco, Mr K. Kresoja, Professor S. Konstantinides

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources